Amendment to Award Agreements This agreement (the "Agreement") is entered into as of December 30, 2005 by Nuveen Investments, Inc. ("Nuveen") and Timothy R. Schwertfeger (the "Executive"). WHEREAS, Nuveen and the Executive are parties to various award...Award Agreements • January 10th, 2006 • Nuveen Investments Inc • Investment advice
SEPARATION AGREEMENT, RELEASE AND AMENDMENT TO AWARD AGREEMENTSAward Agreements • June 5th, 2009 • Firstcity Financial Corp • Short-term business credit institutions
This Separation Agreement, Release and Amendment to Award Agreements (“Agreement”) is made and entered into on June 4, 2009 to be effective as of June 2, 2009 (the “Effective Date”), by and between Richard J. Vander Woude (hereinafter referred to as “Employee”), FirstCity Servicing Corporation. (herein referred to as “FCSC”), and FirstCity Financial Corporation (herein referred to as “FCFC”).
AMENDMENT TO 2022 & 2024 AWARD AGREEMENTS ISSUED UNDER THE 2014 EQUITY INCENTIVE PLANAward Agreements • May 1st, 2024 • LendingClub Corp • Personal credit institutions • California
This AMENDMENT TO 2022 & 2024 AWARD AGREEMENTS (this “Amendment”), dated as of April 30, 2024 (the “Effective Date”), is entered into by and between LENDINGCLUB CORPORATION, a Delaware corporation (the “Company”), and Scott Sanborn (“Participant”), and amends the following award agreements entered into by and between the Company and the Participant (collectively, the “Award Agreements”):
AMENDMENT TO AWARD AGREEMENTSAward Agreements • October 27th, 2006 • Matrix Service Co • Construction - special trade contractors • Delaware
THIS AMENDMENT TO AWARD AGREEMENTS (this “Amendment”) is made and entered into as of the 23rd day of October, 2006, by and between MATRIX SERVICE COMPANY, a Delaware corporation (“Company”), and HUGH E. BRADLEY, an individual (“Director”).
ORTHO-CLINICAL DIAGNOSTICS HOLDINGS PLC OMNIBUS AMENDMENT TO AWARD AGREEMENTSAward Agreements • April 7th, 2022 • Ortho Clinical Diagnostics Holdings PLC • In vitro & in vivo diagnostic substances
This Omnibus Amendment to Award Agreements (the “Amendment”) amends those outstanding award agreements described below (the “Award Agreements”) relating to share option awards, restricted share units and restricted shares (each an “Award”) granted by Ortho Clinical Diagnostics Holdings plc or its predecessors (the “Company”) under the Company’s 2014 Equity Incentive Plan or the Company’s 2021 Equity Incentive Plan (each a “Plan” and together, the “Plans”). Capitalized terms not defined herein shall have the meanings set forth in the respective Plan. This Amendment does not, however, amend the terms of, and does not apply to, any Award that is covered by an individual amendment or similar agreement addressing the impact of the Combinations (as defined below) thereon.
SENSATA TECHNOLOGIES HOLDING PLC AMENDMENT TO AWARD AGREEMENTSAward Agreements • April 29th, 2020 • Sensata Technologies Holding PLC • Industrial instruments for measurement, display, and control
This Amendment to Award Agreements (this “Amendment”) is entered into on February 29, 2020 (the “Effective Date”) by and between Sensata Technologies Holding plc (the “Company”) and Martha Sullivan (the “Participant”). Capitalized terms used herein, but not otherwise defined, shall have the meanings given to such terms in the Sensata Technologies Holding plc First Amended and Restated 2010 Equity Incentive Plan (as amended, the “Plan”)
FORM OF OMNIBUS AMENDMENT TO AWARD AGREEMENTSAward Agreements • November 12th, 2019 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores
This Omnibus Amendment to Award Agreements (“Amendment”) is made and entered into, as of the date set forth on the signature page hereto, by and between Diplomat Pharmacy, Inc., a Michigan corporation (“Company”), and __________ (“Grantee”).
